APA (7th ed.) Citation

Sehrawat, T., Jindal, A., Kohli, P., Thour, A., Kaur, J., Sachdev, A., & Gupta, Y. (2018). Utility and Limitations of Glycated Hemoglobin (HbA1c) in Patients with Liver Cirrhosis as Compared with Oral Glucose Tolerance Test for Diagnosis of Diabetes. Diabetes Therapy, 9(1), 243. https://doi.org/10.1007/s13300-017-0362-4

Chicago Style (17th ed.) Citation

Sehrawat, Tejasav, Anuraag Jindal, Paaras Kohli, Amit Thour, Jasbinder Kaur, Atul Sachdev, and Yashdeep Gupta. "Utility and Limitations of Glycated Hemoglobin (HbA1c) in Patients with Liver Cirrhosis as Compared with Oral Glucose Tolerance Test for Diagnosis of Diabetes." Diabetes Therapy 9, no. 1 (2018): 243. https://doi.org/10.1007/s13300-017-0362-4.

MLA (9th ed.) Citation

Sehrawat, Tejasav, et al. "Utility and Limitations of Glycated Hemoglobin (HbA1c) in Patients with Liver Cirrhosis as Compared with Oral Glucose Tolerance Test for Diagnosis of Diabetes." Diabetes Therapy, vol. 9, no. 1, 2018, p. 243, https://doi.org/10.1007/s13300-017-0362-4.